Guided Therapeutics (GTHP) Other Non-Current Assets (2016 - 2026)

Guided Therapeutics has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $17000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets changed 0.0% year-over-year to $17000.0; the TTM figure through Jun 2026 stood at $17000.0 (changed 0.0% YoY), while the FY2025 annual figure was $17000.0, changed 0.0% from the prior year.
• Other Non-Current Assets came in at $17000.0 for Q2 2026 at Guided Therapeutics, roughly flat from $17000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $17000.0 in Q1 2022 to a low of $17000.0 in Q1 2022.
• Average Other Non-Current Assets over 5 years is $17000.0, with a median of $17000.0 recorded in 2022.
• The largest YoY upside for Other Non-Current Assets was 0.0% in 2022 against a maximum downside of 5.56% in 2022.
• Over 5 years, Other Non-Current Assets stood at $17000.0 in 2022, then changed by 0.0% to $17000.0 in 2023, then changed by 0.0% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025, then changed by 0.0% to $17000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $17000.0 in Q2 2026, $17000.0 in Q1 2026, and $17000.0 in Q4 2025.